Jim Simons’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $397K | Sell |
361,339
-282,438
| -44% | -$335K | ﹤0.01% | 2691 |
|
|
2026
Q1 | $1.12M | Buy |
643,777
+90,613
| +16% | +$149K | ﹤0.01% | 2212 |
|
|
2025
Q4 | $963K | Sell |
553,164
-263,175
| -32% | -$580K | ﹤0.01% | 2304 |
|
|
2025
Q3 | $1.91M | Buy |
816,339
+488,210
| +149% | +$935K | ﹤0.01% | 2111 |
|
|
2025
Q2 | $668K | Buy |
328,129
+282,301
| +616% | +$541K | ﹤0.01% | 2692 |
|
|
2025
Q1 | $74.7K | Sell |
45,828
-196,477
| -81% | -$394K | ﹤0.01% | 3234 |
|
|
2024
Q4 | $443K | Sell |
242,305
-88,761
| -27% | -$393K | ﹤0.01% | 2898 |
|
|
2024
Q3 | $1.91M | Sell |
331,066
-79,500
| -19% | -$656K | ﹤0.01% | 2052 |
|
|
2024
Q2 | $3.32M | Sell |
410,566
-39,700
| -9% | -$418K | 0.01% | 1562 |
|
|
2024
Q1 | $6.25M | Sell |
450,266
-157,849
| -26% | -$1.36M | 0.01% | 1269 |
|
|
2023
Q4 | $3.72M | Buy |
608,115
+200,657
| +49% | +$990K | 0.01% | 1542 |
|
|
2023
Q3 | $1.9M | Sell |
407,458
-45,565
| -10% | -$252K | ﹤0.01% | 1898 |
|
|
2023
Q2 | $2.43M | Buy |
453,023
+232,998
| +106% | +$1.88M | ﹤0.01% | 1864 |
|
|
2023
Q1 | $2.16M | Buy |
220,025
+5,650
| +3% | +$96.3K | ﹤0.01% | 1983 |
|
|
2022
Q4 | $4.01M | Buy |
214,375
+20,733
| +11% | +$470K | 0.01% | 1650 |
|
|
2022
Q3 | $4.01M | Buy |
193,642
+62,184
| +47% | +$1.59M | 0.01% | 1575 |
|
|
2022
Q2 | $2.73M | Buy |
131,458
+98,635
| +301% | +$2.78M | ﹤0.01% | 1970 |
|
|
2022
Q1 | $1.41M | Buy |
+32,823
| New | +$1.48M | ﹤0.01% | 2486 |
|
|
2020
Q2 | – | Sell |
-50,260
| Closed | -$4.49M | – | 3591 |
|
|
2020
Q1 | $4.49M | Buy |
50,260
+20,302
| +68% | +$1.25M | ﹤0.01% | 1632 |
|
|
2019
Q4 | $1.19M | Buy |
29,958
+18,716
| +166% | +$563K | ﹤0.01% | 2551 |
|
|
2019
Q3 | $277K | Sell |
11,242
-6,648
| -37% | -$202K | ﹤0.01% | 3059 |
|
|
2019
Q2 | $631K | Sell |
17,890
-29,133
| -62% | -$1.16M | ﹤0.01% | 2905 |
|
|
2019
Q1 | $2.1M | Buy |
47,023
+19,083
| +68% | +$962K | ﹤0.01% | 2284 |
|
|
2018
Q4 | $1.34M | Sell |
27,940
-3,342
| -11% | -$203K | ﹤0.01% | 2440 |
|
|
2018
Q3 | $2.09M | Buy |
31,282
+5,309
| +20% | +$296K | ﹤0.01% | 2249 |
|
|
2018
Q2 | $1.22M | Sell |
25,973
-3,175
| -11% | -$175K | ﹤0.01% | 2517 |
|
|
2018
Q1 | $1.65M | Sell |
29,148
-1,184
| -4% | -$64.1K | ﹤0.01% | 2434 |
|
|
2017
Q4 | $1.5M | Buy |
+30,332
| New | +$1.88M | ﹤0.01% | 2489 |
|
|
2016
Q1 | – | Sell |
-32,732
| Closed | -$2.64M | – | 3436 |
|
|
2015
Q4 | $2.64M | Buy |
+32,732
| New | +$2.61M | 0.01% | 1931 |
|
Other funds holding INO
Jim Simons's INO Position: Q2 2026 in Review
Jim Simons reduced its Inovio Pharmaceuticals (INO) stake by 44% in Q2 2026, selling an estimated $335K and leaving 361,339 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #2691.
Jim Simons first reported a position in INO in Q4 2015 and has held it in 29 quarters since. The position peaked at $6.25M in Q1 2024. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.
- Jim Simons held 361,339 shares of Inovio Pharmaceuticals worth $397K as of Q2 2026.
- Jim Simons sold 282,438 Inovio Pharmaceuticals shares in Q2 2026, an estimated $335K.
- Inovio Pharmaceuticals made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2691 holding.
- Jim Simons first reported a position in Inovio Pharmaceuticals in Q4 2015 and has held it in 29 quarters since.
- Jim Simons's Inovio Pharmaceuticals position peaked at $6.25M in Q1 2024.
- 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.